The Technical AnalystExchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Nunzia Pharmaceutical Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0030
America/New_York / 18 jul 2023 @ 15:16
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1.304 mill |
| EPS: | -0.300 |
| P/E: | -0.0100 |
| Earnings Date: | N/A |
| SharesOutstanding: | 434.52 mill |
| Avg Daily Volume: | 0 mill |
| RATING 2023-08-15 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | |||
| Asset | n/a | n/a | n/a | |||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0100 | sector: PE 29.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.0100 | industry: PE 31.46 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0010 - 0.0050 ( +/- 66.67%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2006-10-30 | Henry G David | Buy | 25 000 | Common Stock |
| 2006-10-18 | Henry G David | Buy | 100 000 | Common Stock |
| 2006-06-14 | Henry G David | Buy | 10 000 | Common Stock |
| 2006-05-03 | Henry G David | Buy | 3 913 | Common Stock |
| 2006-05-02 | Henry G David | Buy | 55 000 | Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 72 transactions |
| Buy: 97 845 914 | Sell: 60 942 223 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0030 (0.00% ) |
| Volume | 0.0000 mill |
| Avg. Vol. | 0 mill |
| % of Avg. Vol | 0 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NUNZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NUNZ
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.